Alprostadil

This classification denotes a prostaglandin analogue with the molecular formula C20H34O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F5TD010360, chemically known as 11.alpha., 15.alpha.-dihydroxy-9-oxo-13-trans-prostenoic acid but generally known as alprostadil, which bears US NIH Compound Identifier 214. Alprostadil most often comes in alfadex and prostoglandinalfadex and prostoglandin forms. European Medicines Agency schedules Alprostadil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05372MIG. The term ALPROSTADIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules alprostadil in its Anatomical Therapeutic Chemical (ATC) Classification. ALPROSTADIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule alprostadil under HS 29375000 and SITC 54156. As of Q4 2014, ALPROSTADIL remains the US FDA Preferred Term for this commodity. Alprostadil bears US NLM identifiers UMLS ID C0592016 and NCI Concept Code C28816. SMILES: OC1C(C(CCCCCCC(=O)O)C(=O)C1)/C=C/C(O)CCCCC.